Young‐Im Kim

ORCID: 0000-0003-2560-8621
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer, Hypoxia, and Metabolism
  • Metabolism, Diabetes, and Cancer
  • RNA modifications and cancer
  • Cardiovascular Function and Risk Factors
  • Chronic Lymphocytic Leukemia Research
  • Mitochondrial Function and Pathology
  • Autophagy in Disease and Therapy
  • Epigenetics and DNA Methylation
  • Pancreatic and Hepatic Oncology Research
  • Cancer-related Molecular Pathways
  • Advanced Breast Cancer Therapies
  • Glycosylation and Glycoproteins Research
  • Health and Wellbeing Research
  • Sarcoma Diagnosis and Treatment
  • Adipose Tissue and Metabolism
  • Pancreatic function and diabetes
  • RNA Research and Splicing
  • interferon and immune responses
  • Diverse Approaches in Healthcare and Education Studies
  • Electromagnetic Fields and Biological Effects
  • Ultrasound and Hyperthermia Applications

Center for Cancer Research
2021-2023

National Cancer Institute
2021-2023

Ajou University
2022

National Institutes of Health
2021

Understanding functional interactions between cancer mutations is an attractive strategy for discovering unappreciated pathways and developing new combination therapies to improve personalized treatment. However, distinguishing driver gene pairs from passenger remains challenging. Here, we designed integrated omics approach identify by leveraging genetic interaction analyses of top mutated breast genes the proteomics interactome data their encoded proteins. This identified that PIK3CA...

10.1158/0008-5472.can-22-2525 article EN Cancer Research 2023-02-14

The absence of prominent, actionable genetic alternations in osteosarcomas (OS) implies that transcriptional and epigenetic mechanisms significantly contribute to the progression this life-threatening form cancer. Therefore, identification potential events promote survival OS cells could be key devising targeted therapeutic approaches for OS. We have previously shown RUNX2 is a transcription factor (TF) essential cell survival. Unfortunately, network or circuitry regulated by still largely...

10.1186/s13578-023-01088-2 article EN cc-by Cell & Bioscience 2023-07-25

The CBFB gene is frequently mutated in several types of solid tumors. Emerging evidence suggests that a tumor suppressor breast cancer. However, our understanding the suppressive function remains incomplete. Here, we analyze genetic interactions between mutations and other highly genes human cancer datasets find TP53 are mutually exclusive, suggesting functional association p53. Integrated genomic studies reveal TAp73 common transcriptional target cooperates with p53 to maintain expression,...

10.1371/journal.pgen.1009553 article EN public-domain PLoS Genetics 2021-05-04

<div>Abstract<p>Understanding functional interactions between cancer mutations is an attractive strategy for discovering unappreciated pathways and developing new combination therapies to improve personalized treatment. However, distinguishing driver gene pairs from passenger remains challenging. Here, we designed integrated omics approach identify by leveraging genetic interaction analyses of top mutated breast genes the proteomics interactome data their encoded proteins. This...

10.1158/0008-5472.c.6599673.v2 preprint EN 2024-09-16

<div>Abstract<p>Understanding functional interactions between cancer mutations is an attractive strategy for discovering unappreciated pathways and developing new combination therapies to improve personalized treatment. However, distinguishing driver gene pairs from passenger remains challenging. Here, we designed integrated omics approach identify by leveraging genetic interaction analyses of top mutated breast genes the proteomics interactome data their encoded proteins. This...

10.1158/0008-5472.c.6599673 preprint EN 2023-04-14

<div>Abstract<p>Understanding functional interactions between cancer mutations is an attractive strategy for discovering unappreciated pathways and developing new combination therapies to improve personalized treatment. However, distinguishing driver gene pairs from passenger remains challenging. Here, we designed integrated omics approach identify by leveraging genetic interaction analyses of top mutated breast genes the proteomics interactome data their encoded proteins. This...

10.1158/0008-5472.c.6599673.v1 preprint EN 2023-04-14
Coming Soon ...